ESR1 and breast carcinoma: Conclusively, the uniformity in the staining and the ease of detection was appreciable in aptamer stained tissues; this suggests that the selected ERaptD4 aptamer could be an efficient alternate to ERα-antibodies in clinical applications, such as histochemical examination of ERα in breast cancer samples.